BioInfoExperts

What BioInfoExperts does

BioInfoExperts LLC is a privately held pathogen genomics company founded in 2012 and headquartered in Thibodaux, Louisiana, with a BSL-2 molecular research laboratory at the University of Florida's Sid Martin Bio-incubator in Alachua, Florida. The company provides end-to-end genetic characterization, molecular research, and bioinformatics services for infectious disease dynamics and molecular surveillance of pathogens, including viruses (HIV, CMV, EBV, HCV, HPV, Zika, WNV, SIV, RVF, SARS-CoV-2), bacteria, and—most recently—AAV gene therapy vectors. Its service portfolio spans experimental design, DNA/RNA extraction, PCR, high-throughput sequencing on Illumina and PacBio platforms, single genome sequencing via Sanger + limiting-dilution, NGS-based AAV characterization, and customizable data analytics and reporting. BioInfoExperts also develops FoxSeq, a proprietary patented cloud-based software platform housed in a wholly-owned subsidiary (FoxSeq LLC, incorporated 2020) that automates pathogen sequence analysis and delivers interactive visualizations.

The company operates a hybrid lab-services-plus-software model with a quote-based, non-publicly-disclosed pricing structure. Revenue is generated through four streams: professional lab services (BSL-2 wet lab sequencing), FoxSeq software licensing to healthcare organizations and industrial clients (including Ochsner Health, LSU Health Sciences Center New Orleans, New Orleans Department of Health, and an oil & gas operator), bioinformatics consulting, and gene therapy characterization services. Customer segments are organized vertically, with healthcare systems and academic research institutions as primary targets and government health departments, gene therapy manufacturers/CDMOs, and industrial clients as secondary segments. Go-to-market is enterprise field sales supplemented by government contracting; the company has secured non-dilutive funding from NSF SBIR, FDA SBIR, and a $4 million BARDA Project NextGen award in February 2024 for COVID-19 genomic sequencing.

The leadership team is small and domain-deep: founder and CEO Susanna Lamers has operated genetic analysis consulting businesses since 1990, CTO Rebecca Rose (PhD, AWS Cloud Practitioner) leads FoxSeq software development, and Laboratory Director David J. Nolan runs the Alachua wet lab. The company employs 1–10 people total and has no disclosed traditional venture financing, relying instead on SBIR grants and contract revenue. BioInfoExperts markets primarily through its website, peer-reviewed scientific publications, conference presentations (including ASGCT), earned media (NPR), and peer referrals from healthcare customers such as Ochsner Health, LSU Health, UCSF, and UF Health Jacksonville.

Name

BioInfoExperts

Legal name

BioInfoExperts LLC

Website

https://bioinfox.com

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

1–10 employees

Short description

BioInfoExperts is a privately held pathogen genomics company providing BSL-2 laboratory sequencing services and the proprietary FoxSeq cloud analytics platform to healthcare systems, academic research institutions, government agencies, gene therapy manufacturers, and industrial clients.

Ownership category

akta.pro rank

Product category

Pathogen Genomics Services

NAICS

Medical and Diagnostic Laboratories (6215), Medical Laboratories (621511), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Other Scientific and Technical Consulting Services (54169)

SIC

Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731), In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Molecular & Genetic Testing (PCR/NGS/qPCR) (HLAGADAF)

akta.pro secondary industries

Bioinformatics & Multi-omics Analysis Software (HLAGAJAD), Genomics & Molecular Diagnostics (Trial Support) (HLAGAEAD), Molecular Diagnostics & Genomics Laboratories (HLAFAMAE), Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays) (HLAAALAL)

Keywords

• Pathogen genomics services
• Molecular sequencing laboratory
• Bioinformatics consulting
• Viral vector characterization
• Infectious disease surveillance

Headquarters

HQ city

Thibodaux

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales

Revenue model

1. Laboratory Services: Provides complete suite of pathogen sequencing services including project and experimental design, DNA/RNA quantitation, extraction, PCR, and high-throughput sequencing on Illumina and PacBio platforms. BSL-2 wet lab testing services.
2. FoxSeq Software Licensing: FoxSeq cloud-based platform licensed to healthcare organizations, research institutions, government agencies, and industrial clients for genomic pathogen sequencing analysis. Licensed to Ochsner Health, LSU Health Sciences Center, New Orleans Department of Health, and oil and gas industry.
3. Bioinformatics Consulting: End-to-end assistance with pathogen genomics research including experimental design, sequence data generation, computation, manuscript and grant writing, data visualization, and reporting.
4. Gene Therapy Characterization: Genetic characterization assays for gene therapy products including AAV vectors, enabling assessment of product purity, length variation quantification, contaminating DNA, and single nucleotide mutation rates.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

BioInfoExperts provides pathogen genomics laboratory and bioinformatics services, combining a BSL-2 molecular research laboratory with the proprietary FoxSeq cloud-based software platform to perform genetic characterization of viruses, bacteria, and AAV gene therapy vectors. Offerings span experimental design, wet-lab sequencing on Illumina and PacBio instruments, automated bioinformatics analysis, and reporting for healthcare systems, research institutions, government agencies, and gene therapy manufacturers. The company also delivers end-to-end pathogen genomics consulting including manuscript and grant writing support.

Product overview

BioInfoExperts operates as a pathogen genomics company offering a portfolio of integrated products and services. The core offering is FoxSeq, a proprietary cloud-based software platform that automates pathogen sequencing data analysis and delivers actionable results. This software platform is complemented by an on-site molecular research laboratory at UF Sid Martin Bio-incubator providing BSL-2 wet lab services including sample processing, sequencing on Illumina and PacBio platforms, and experimental design. The company has recently expanded into gene therapy services, offering genetic characterization of viral vectors like rAAVs using single genome sequencing and next-generation sequencing methods. The product portfolio also includes data analytics services, pathogen genomics consulting, and multiple sequencing approaches (whole genome, single genome, RNA SEQ, metagenomic, and AAV). FoxSeq serves as the unified platform delivering results across all service lines.

Differentiator

Problem solved

Functional benefit

Brands

• FoxSeq: Proprietary cloud-based software platform developed by BioInfoExperts that reduces the complexity of incorporating pathogen sequencing into healthcare workflows. Provides automated analyses of raw or aligned sequence data for different viruses and bacteria with interactive and customizable visualizations.

Products and services

• FoxSeq Proprietary cloud-based software platform that reduces the complexity of incorporating pathogen sequencing into healthcare workflows. Provides automated analyses of raw or aligned sequence data for viruses and bacteria with interactive, customizable visualizations, licensed to healthcare organizations, research institutions, government agencies, and industrial clients.
• Molecular Research Laboratory Services BSL-2 wet lab services including project and experimental design, complete suite of pathogen sequencing services (DNA/RNA quantitation, extraction, PCR) and high-throughput sequencing on Illumina and PacBio platforms for pathogen research.
• Gene Therapy Characterization Services Genetic characterization assays for gene therapy products including rAAV vectors, offering single genome sequencing, next-generation sequencing, quantification of length variation, contaminating DNA detection, and single nucleotide mutation rate analysis for product purity assessment.
• Data Analytics Services Analyses based on pathogen targets, sequencing approaches, and research questions, with customized data visualizations and collaborative report development positioned as an extension of the customer's research team.
• Pathogen Genomics Consulting End-to-end pathogen genomics research assistance including experimental design, sequence data generation, computation, manuscript and grant writing, data visualization, and reporting for infectious disease and public health research teams.
• Sequencing Approaches Multiple sequencing methods offered as discrete services, including Whole Genome Sequencing, Single Genome Sequencing (Sanger with limiting-dilution amplification), RNA Sequencing, Metagenomic Sequencing, and AAV vector sequencing for pathogen characterization.

Quantifiable outcome

• Enables rapid whole genome sequencing of SARS-CoV-2 from regional samples (first New Orleans sequences)
• +1 more outcomes

Named customers4 records

Segments5 records

Ideal customer profiles6 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature5 records

Partnerships

Seven partnerships are on record, tiered minor and core.

• Tulane University / Dr. Chenzhong LiminorStrategic or Co-development Partner · 1 April 2022Collaboration with Dr. Chenzhong Li of Tulane University on breakthrough technologies, featured together on NPR's Out to Lunch broadcast.
• Ochsner HealthcoreGTM or Marketing Partner · 1 November 2021Licensed FoxSeq cloud-based platform integrating pathogen genetics with clinical data and contact tracing. Collaboration on first whole genome sequences of SARS-CoV-2 from New Orleans area.
• LSU Health Sciences Center New OrleanscoreGTM or Marketing Partner · 1 November 2021Licensed FoxSeq platform for genomic pathogen sequencing analysis. Judith S. Crabtree serves as Director of Precision Medicine Program and Genomics Core.
• New Orleans Department of HealthcoreGTM or Marketing Partner · 1 November 2021Licensed FoxSeq platform for community pathogen surveillance and genomic sequencing analysis supporting public health response.
• Oil and Gas IndustryminorOEM/ Whitelabel/ Licensing Partner · 1 November 2021Oil and gas industry adopted FoxSeq for genomic pathogen sequencing analysis to better understand transmission in vulnerable employee populations.
• LSU Center for Computation and TechnologyminorStrategic or Co-development Partner · 1 October 2021Collaboration with LSU Center for Computation and Technology for 'Precision Epidemiology' products and services, delivering pathogen genomics capabilities.
• UF Sid Martin Bio-incubatorcoreStrategic or Co-development PartnerLaboratory located at world-renowned UF Sid Martin Bio-incubator in Alachua, Florida. Provides access to bioincubator resources and innovation ecosystem.

Scale indicators3 records

Recent moves7 records

Expansion highlights6 records

Broad incumbents

• QIAGEN: Global molecular diagnostics and bioinformatics leader (QIAGEN Digital Insights, QIAseq pathogen panels) serving clinical, public-health, and pharma customers — provides the broader incumbent alternative to BioInfoExperts' combined molecular testing + analytics offering.
• BGI Genomics: Large-scale global sequencing services and molecular diagnostics provider with significant pathogen surveillance and public-health testing capacity — comparable end-to-end lab-plus-bioinformatics service model.
• Eurofins Genomics: Global contract genomics services provider offering Sanger, NGS, and bioinformatics for pharma, academic, and clinical customers — comparable outsourced lab services for pathogen and gene-therapy characterization.
• Illumina (IDbyDNA / DRAGEN): Sequencing platform leader whose DRAGEN bioinformatics and IDbyDNA pathogen-identification subsidiary compete with FoxSeq for genomic pathogen analytics workflows installed across hospital and public-health labs.
• bioMérieux: Established in vitro diagnostics and industrial microbiology company with BioBall/BioBall Cloud, GENE-UP pathogen detection, and clinical microbiology workflows for hospitals and industrial customers — overlaps with BioInfoExperts' pathogen detection and surveillance focus.
• Cepheid (Danaher): Molecular diagnostics platform (GeneXpert) widely deployed in hospitals and public-health labs for pathogen detection including SARS-CoV-2 and infection control — overlaps with BioInfoExperts' healthcare-system infectious disease customers.
• Tempus AI: AI-enabled precision medicine and multi-omics data platform serving hospitals, pharma, and researchers with genomic testing pipelines and cloud analytics — comparable lab-plus-software stack for healthcare and translational research customers.

Emerging players

• Adaptive Biotechnologies: Immune-sequencing company with clonoSEQ and T-Detect product lines applying genomic sequencing to immune-response and infectious-disease characterization — comparable sequencing-plus-software platform play targeting clinical and pharma markets.
• GeneDx (Sema4): Clinical genomics and rare-disease sequencing services company (spun out of Sema4) combining high-throughput NGS labs with cloud-based clinical interpretation — directly comparable to BioInfoExperts' sequencing-services-plus-bioinformatics model for healthcare customers.

Direct peers

• Theiagen Genomics: Public-health-focused bioinformatics consulting firm offering pathogen genomics services and analysis pipelines (e.g., tools for TB, SARS-CoV-2, viral surveillance) to state health departments, CDC, and academic customers — directly comparable to BioInfoExperts' pathogen genomics services plus FoxSeq-style analytics stack.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries1 record

Funding overview

Funding rounds2 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BioInfoExperts